Free Trial

Flora Growth (FLGC) Competitors

Flora Growth logo
$0.64 +0.04 (+6.79%)
Closing price 07/3/2025 03:54 PM Eastern
Extended Trading
$0.64 0.00 (0.00%)
As of 07/3/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FLGC vs. MGX, IFRX, KRON, OTLK, OSTX, CRVO, AVTX, IPA, RENB, and KLRS

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Metagenomi (MGX), InflaRx (IFRX), Kronos Bio (KRON), Oncobiologics (OTLK), OS Therapies (OSTX), CervoMed (CRVO), Avalo Therapeutics (AVTX), ImmunoPrecise Antibodies (IPA), Renovaro (RENB), and Kalaris Therapeutics (KLRS). These companies are all part of the "pharmaceutical products" industry.

Flora Growth vs. Its Competitors

Metagenomi (NASDAQ:MGX) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Flora Growth has higher revenue and earnings than Metagenomi. Metagenomi is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Metagenomi$52.29M1.18-$78.06M-$2.11-0.78
Flora Growth$59.51M0.24-$15.91M-$0.98-0.65

Metagenomi has a beta of -0.38, suggesting that its stock price is 138% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.97, suggesting that its stock price is 97% more volatile than the S&P 500.

Flora Growth has a net margin of -24.85% compared to Metagenomi's net margin of -172.21%. Metagenomi's return on equity of -31.21% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Metagenomi-172.21% -31.21% -22.21%
Flora Growth -24.85%-216.49%-45.56%

Metagenomi currently has a consensus target price of $13.00, suggesting a potential upside of 685.97%. Flora Growth has a consensus target price of $4.00, suggesting a potential upside of 529.92%. Given Metagenomi's stronger consensus rating and higher probable upside, research analysts clearly believe Metagenomi is more favorable than Flora Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Metagenomi
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Flora Growth
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Flora Growth had 4 more articles in the media than Metagenomi. MarketBeat recorded 4 mentions for Flora Growth and 0 mentions for Metagenomi. Flora Growth's average media sentiment score of 0.79 beat Metagenomi's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media.

Company Overall Sentiment
Metagenomi Neutral
Flora Growth Positive

36.0% of Flora Growth shares are held by institutional investors. 17.8% of Metagenomi shares are held by insiders. Comparatively, 12.6% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Flora Growth beats Metagenomi on 9 of the 16 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$13.43M$10.52B$5.53B$9.05B
Dividend YieldN/A2.07%5.24%4.03%
P/E Ratio-0.6516.4627.5220.22
Price / Sales0.2429.54421.02118.64
Price / CashN/A22.9936.8958.07
Price / Book2.053.668.045.67
Net Income-$15.91M$235.40M$3.18B$249.13M
7 Day Performance4.10%2.15%2.90%3.28%
1 Month Performance1.76%3.38%3.70%5.55%
1 Year Performance-30.98%-10.18%36.15%21.12%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FLGC
Flora Growth
3.0299 of 5 stars
$0.64
+6.8%
$4.00
+529.9%
-34.9%$13.43M$59.51M-0.65280News Coverage
MGX
Metagenomi
1.7961 of 5 stars
$1.48
+1.4%
$13.00
+778.4%
-57.7%$54.58M$52.29M-0.70236Positive News
Gap Up
IFRX
InflaRx
2.7029 of 5 stars
$0.79
-2.2%
$6.60
+735.4%
-50.6%$54.23M$180K-0.9660News Coverage
KRON
Kronos Bio
3.4813 of 5 stars
$0.88
+1.5%
$1.63
+84.7%
-22.1%$53.72M$9.85M-0.82100
OTLK
Oncobiologics
1.6785 of 5 stars
$1.60
flat
$9.60
+500.0%
-74.4%$53.71MN/A-1.7620Positive News
OSTX
OS Therapies
2.6531 of 5 stars
$1.88
+2.2%
$18.00
+857.4%
N/A$52.82MN/A-2.19N/ANews Coverage
CRVO
CervoMed
3.303 of 5 stars
$6.28
+3.8%
$27.63
+339.9%
-64.0%$52.65M$9.74M-2.884Positive News
Gap Down
AVTX
Avalo Therapeutics
3.0623 of 5 stars
$4.99
+4.4%
$30.00
+501.2%
-57.0%$51.76M$440K0.0040News Coverage
IPA
ImmunoPrecise Antibodies
1.7684 of 5 stars
$1.06
-4.5%
$4.00
+277.4%
+33.5%$50.80M$18.16M-0.9180News Coverage
RENB
Renovaro
1.1766 of 5 stars
$0.29
-1.3%
N/A-82.4%$50.38MN/A-0.3820Gap Up
KLRS
Kalaris Therapeutics
N/A$2.67
+1.9%
N/AN/A$49MN/A0.00110Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:FLGC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners